We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide (ACTIHUMEUR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02803632
Recruitment Status : Recruiting
First Posted : June 17, 2016
Last Update Posted : June 17, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
An excess suicide-related morbidity is observed among young people in the Picardie region, as reflected by the > 100% occupation rate of the Amiens University Hospital Adolescent Medicine Unit. New approaches have been proposed to these problems that have led us to reorganize our diagnostic practices: 1) more precise characterization of suicidal behaviour by using standardized instruments such as the French version of the Columbia-Suicide Severity Rating Scale developed by Posner (C-SSRS); 2) new clinical entities, such as disruptive mood dysregulation disorder, are now proposed in international classifications (DSM 5 field trial); 3) investigations such as recording of the circadian rhythm of motor activity by actigraphy are being studied as a laboratory complement to psychiatric diagnosis.

Condition or disease Intervention/treatment
Suicide, Attempted Behavioral: questionnaires Device: actigraphic recording

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 140 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Clinical and Actigraphic Profile of Young Patients Admitted for Attempted Suicide: Investigation of Disruptive Mood Dysregulation Disorder
Study Start Date : November 2012
Estimated Primary Completion Date : November 2018
Estimated Study Completion Date : November 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Suicide
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: suicide attempt
questionnaires actigraphic recording
Behavioral: questionnaires Device: actigraphic recording


Outcome Measures

Primary Outcome Measures :
  1. The variable absence / presence of the disruptive mood dysregulation disorder (DMDD) [ Time Frame: Day 0 ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   6 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • children/adolescents admitted after a suicide attempt

Exclusion Criteria:

  • severe depression
  • mental retardation
  • pervasive developmental disorder
  • active psychotic episode,
  • drug and alcohol abuse at the time of admission
  • organic sleep-wake disorders (sleep-related respiratory and motor disorders, narcolepsy)
  • any contraindication formulated by the clinical team
  • patients not covered by French national health insurance, patients deprived of their freedom as stipulated in Article L.1121-6 of the French Public Health Code
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02803632


Contacts
Contact: Jean-Marc GUILE, PhD +33 3 22 08 76 28 guile.jean-marc@chu-amiens.fr

Locations
France
CHU Amiens Recruiting
Amiens, France, 80054
Contact: Jean-Marc GUILE, PhD    +33 3 22 08 76 28    guile.jean-marc@chu-amiens.fr   
AP HP Recruiting
Paris, France, 75004
Sponsors and Collaborators
Centre Hospitalier Universitaire, Amiens
Investigators
Principal Investigator: Jean-Marc GUILE, PhD CHU Amiens
More Information

Responsible Party: Centre Hospitalier Universitaire, Amiens
ClinicalTrials.gov Identifier: NCT02803632     History of Changes
Other Study ID Numbers: AOL11-DR -GUILE
First Posted: June 17, 2016    Key Record Dates
Last Update Posted: June 17, 2016
Last Verified: June 2016

Keywords provided by Centre Hospitalier Universitaire, Amiens:
young
disruptive mood dysregulation disorder
actigraphic profile

Additional relevant MeSH terms:
Suicide
Suicide, Attempted
Self-Injurious Behavior
Behavioral Symptoms